
|Videos|November 13, 2020
AAO 2020: Genentech provides update on presentations, product portfolio
Author(s)OT Staff Reports
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.
Advertisement
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of some of the company’s podium presentations from the Port Delivery System with ranibizumab to the novel pipeline molecule, faricimab.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Preclinical study explores contact lens–based neuromodulation for depression
2
MacTel masquerades: How to spot what others miss
3
QA102 data suggest signal in intermediate dry AMD, but insignificant drusen volume change
4
Tinlarebant earns Swiss orphan drug status for Stargardt disease
5























